DifGen Pharmaceuticals
PrivateCompany Overview
DifGen Pharmaceuticals is a pharmaceutical company that specializes in the development and manufacturing of complex, high-barrier-to-entry generic and specialty pharmaceutical products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Quality Management
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DifGen Pharmaceuticals Comparables
Compare DifGen Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cosette Pharmaceuticals, Inc. | 81% | |
| Aurobindo Pharma Limited | 81% | |
| Dr. Reddy's Laboratories | 74% | |
DifGen Pharmaceuticals Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 10, 2025
Grew 16% QoQ, from 115 to 133 employees.
- Jan 13, 2025
Grew 25% QoQ, from 92 to 115 employees.
DifGen Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about DifGen Pharmaceuticals's valuation, stock price, and market status.